Enzyme is projected to decline to $1.29 by 2027, a -35% move from its current price of $2.00. MLN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 22/100 (Extreme Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 5/26/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.87 | $2.00 | $2.14 | +0.04% |
| May 30 | $1.81 | $2.00 | $2.21 | +0.07% |
| May 31 | $1.78 | $2.00 | $2.26 | +0.11% |
| Jun 1 | $1.74 | $2.00 | $2.30 | +0.14% |
| Jun 2 | $1.72 | $2.00 | $2.34 | +0.18% |
| Jun 3 | $1.69 | $2.00 | $2.38 | +0.21% |
| Jun 4 | $1.67 | $2.01 | $2.41 | +0.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.67 | $2.01 | $2.41 | +0.25% |
| Week 2 | $1.55 | $2.01 | $2.61 | +0.50% |
| Week 3 | $1.47 | $2.02 | $2.77 | +0.75% |
| Week 4 | $1.40 | $2.02 | $2.92 | +1.01% |
| Week 5 | $1.34 | $2.03 | $3.05 | +1.26% |
| Week 6 | $1.29 | $2.03 | $3.18 | +1.51% |
| Week 7 | $1.25 | $2.04 | $3.31 | +1.77% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MLN is the official token of Enzyme. Founded in 2017, Enzyme is the global infrastructure for tokenized finance. Enzyme provides industry leaders with a comprehensive suites of Vault-As-A-Service and Financial Instruments products to manage on-chain assets efficiently, optimize operational processes, and develop innovative financial strategies tailored to their unique goals and challenges.
MLN sits within the DeFi, Asset Manager, Polygon Ecosystem, Arbitrum Ecosystem, Ethereum Ecosystem, Real World Assets (RWA), and DeFiance Capital Portfolio categories as part of its ecosystem footprint.
As a native token linked to Enzyme’s suite of on-chain asset solutions, MLN functions within a DeFi and asset-management context that spans multiple major ecosystems and asset classes.
Enzyme launched on March 15, 2017.
Enzyme’s MLN is currently priced at $2.00 with a market capitalization of $6.52M and a global rank of 1485. This places MLN as a relatively small-cap token within the broader DeFi space.
The asset has traded as high as $258.26 and as low as $1.79, illustrating substantial historical volatility between its all-time extremes.
Forecasts outline a year-by-year price path with min/avg/max values and ROI. Near-term expectations are flat to modestly positive (2026: avg $2.00, max $2.14; ROI 0%), while later years show periods of meaningful upside (for example 2033: avg $4.51 with 125.3% ROI) and a very strong longer-run outlook (2050: avg $7.61 with 280.7% ROI).
A major floor 41.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.1% away) — a key level to hold.
The nearest ceiling, 61.9% above — a clean break opens room to run.
A major ceiling 93.0% above — clearing it would confirm fresh momentum.
Key MLN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MLN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.10 | Sell | $2.10 | Sell |
| MA 10 | $2.21 | Sell | $2.25 | Sell |
| MA 20 | $2.61 | Sell | $2.48 | Sell |
| MA 50 | $2.92 | Sell | $2.83 | Sell |
| MA 100 | $3.18 | Sell | $3.25 | Sell |
| MA 200 | $4.05 | Sell | $4.11 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 32.51 | Neutral |
| Stoch RSI (14) | 33.90 | Neutral |
| CCI (20) | -92.26 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | -8.77 | Sell |
| Bollinger %B (20,2) | 0.17 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.05 | Sell |
| Awesome (5,34) | -0.70 | Sell |
| Ultimate (7,14,28) | 17.17 | Buy |
| Momentum (10) | -1.06 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 2.03 | Sell |
| ADX (14) | 20.44 | Sell |
| ATR (14) | 0.13 | Info |
30-day technical picture:
- Sentiment: BEARISH
- RSI14: 30
- SMA50: $2.92
- SMA200: $4.05
- Support: $2.00
- Resistance: $3.24
The 30-day range spans $1.37 to $2.93, highlighting a narrow immediate band around the current price. Annualized volatility sits at 100%, underscoring elevated near-term risk and potential for rapid moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.00 | $2.00 | $2.14 | 0% | Neutral | |
| $0.9305 | $1.29 | $1.95 | -35% | Bearish | |
| $2.05 | $3.02 | $4.83 | +51% | Bullish | |
| $1.92 | $2.99 | $5.02 | +50% | Bullish | |
| $1.70 | $2.76 | $4.82 | +38% | Bullish | |
| $0.8273 | $1.41 | $2.54 | -30% | Bearish | |
| $1.31 | $2.33 | $4.33 | +16% | Neutral | |
| $2.44 | $4.51 | $8.62 | +125% | Bullish | |
| $1.46 | $2.81 | $5.51 | +41% | Bullish | |
| $0.7478 | $1.50 | $3.00 | -25% | Bearish | |
| $0.9823 | $2.18 | $4.81 | +9% | Neutral | |
| $3.43 | $7.61 | $17.51 | +281% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.00 | $2.00 | $2.41 | +0.00% |
| June 2026 | $1.84 | $2.21 | $2.75 | +10.45% |
| July 2026 | $1.69 | $2.07 | $2.64 | -6.46% |
| August 2026 | $1.47 | $1.81 | $2.36 | -12.23% |
| September 2026 | $1.60 | $2.00 | $2.65 | +10.47% |
| October 2026 | $1.68 | $2.12 | $2.85 | +6.03% |
| November 2026 | $1.38 | $1.76 | $2.39 | -17.15% |
| December 2026 | $1.21 | $1.56 | $2.14 | -11.34% |
Click any year to see its month-by-month MLN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Enzyme's 2026 outlook centres on $2.00, within a $2.00 to $2.14 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, MLN could reach as high as $1.95, with a base case around $1.29 and support toward $0.9305 — roughly -35% from $2.00. Expect choppier, lower action through this leg of the cycle.
Expect MLN to range from $2.05 to $4.83 through 2028. The $3.02 average target implies a +51% move from current prices. That is up +133% on the projected 2027 average. Momentum favours further upside here.
The MLN price prediction for 2029 points to an average of $2.99 (low $1.92, high $5.02) — a potential gain of +50% on today's $2.00. Buyers look set to stay in control over this stretch.
In 2030, MLN is projected to trade between $1.70 and $4.82, averaging $2.76 — a potential gain of +38% from today's $2.00. That is -8% versus the projected 2029 average. Momentum favours further upside here.
Enzyme's 2031 outlook centres on $1.41, within a $0.8273 to $2.54 range. That is -49% versus the projected 2030 average. That marks a -30% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2032, MLN could reach as high as $4.33, with a base case around $2.33 and support toward $1.31 — roughly +16% from $2.00. Price action looks broadly range-bound.
Expect MLN to range from $2.44 to $8.62 through 2033. The $4.51 average target implies a +125% move from current prices. That is up +94% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The MLN price prediction for 2034 points to an average of $2.81 (low $1.46, high $5.51) — a potential gain of +41% on today's $2.00. Momentum favours further upside here.
In 2035, MLN is projected to trade between $0.7478 and $3.00, averaging $1.50 — a potential decline of -25% from today's $2.00. That is -47% versus the projected 2034 average. Expect choppier, lower action through this leg of the cycle.
Enzyme's 2040 outlook centres on $2.18, within a $0.9823 to $4.81 range. That is up +46% on the projected 2035 average. That marks a +9% change versus current levels. Price action looks broadly range-bound.
By 2050, MLN could reach as high as $17.51, with a base case around $7.61 and support toward $3.43 — roughly +281% from $2.00. Buyers look set to stay in control over this stretch.
Investing $1,000 in MLN today (≈ 500 MLN) could be worth
$3,806.84
+$2,806.84 (+281%) by 2050 · US Dollar
Based on the average projected MLN price of $7.61 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MLNwould be worth at today's price.
$1,000 invested in MLN on May 27, 2025 (≈ 120.990017 MLN) would be worth
$241.98
-$758.02 (-75.8%) today · 0.24× · US Dollar
Based on a MLN entry price of $8.27 vs. today's $2.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.35 | $850.02 | -15.0% |
| 1 month ago | $3.14 | $636.84 | -36.3% |
| 3 months ago | $3.25 | $614.62 | -38.5% |
| 6 months ago | $5.3 | $377.4 | -62.3% |
| 1 year ago | $8.27 | $241.98 | -75.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MLN forecast.
Our base-case forecast reaches $4.00 around 2033.
Implied market cap at $4.00: $13.11M
The multi-year forecast shows a mosaic of outcomes across the horizon. In 2026 the avg price is $2.00 with a 0% ROI and neutral sentiment. By 2027 the path turns more cautious with min $0.93, avg $1.29, max $1.95 and a -35.3% ROI, signaling a bearish tilt in that year.
The 2028–2030 window shifts to a more bullish tone, with 2028 avg $3.02 (51% ROI) and 2029 avg $2.99 (49.5% ROI), followed by 2030 avg $2.76 (38.1% ROI). In 2033 the forecast jumps to avg $4.51 with 125.3% ROI, underscoring a strong bullish phase, while 2040 shows avg $2.18 and 9.2% ROI.
The long-range view culminates in 2050 with avg $7.61 and 280.7% ROI, a bullish signal at the far horizon. The outlook includes some bear years (e.g., 2031, 2035) but also notable upside in late 2020s and into 2050. These figures are estimates and not guarantees, reflecting a wide range of possible trajectories.
Tap a question to reveal the answer.
Avg $2.76; min $1.70; max $4.82; ROI 38.1%; sentiment BULLISH.
Forecasts show a mix of outcomes: neutral in 2026, bearish in 2027 (-35.3%), bullish in 2028 (51%) and 2029 (49.5%), continuing with 2030 at 38.1% and 2033 at 125.3%; 2040 at 9.2% and 2050 at 280.7%. These are estimates and not guarantees.
Yes. The forecast max reaches $5.02 in 2029 and $8.62 in 2033, indicating that surpassing $5 is within the projected path (with higher potential in later years).
Current price is $2.00; market cap is $6.52M; rank is 1485.
Bearish sentiment with RSI 30; SMA50 $2.92 and SMA200 $4.05. The price sits near support of $2.00 and faces resistance at $3.24; 30-day range is $1.37 to $2.93.
Enzyme Community Discussion
0Share your Enzyme price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.